|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
a The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia;
b Zenyth Therapeutics Limited, Richmond, Australia
Key Words. SOCS-3 • Embryonic stem cells • Endoderm
Correspondence: Lorraine Robb, M.D., Ph.D., The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia. Telephone: 61-39-345-2527; Fax: 61-39-347-0852; e-mail: robb{at}wehi.edu.au
Received July 16, 2005;
accepted for publication August 12, 2005.
Leukemia inhibitory factor (LIF) is required to maintain pluripotency and permit self-renewal of murine embryonic stem (ES) cells. LIF binds to a receptor complex of LIFR-ß and gp130 and signals via the Janus kinasesignal transducer and activator of transcription (JAKSTAT) pathway, with signalling attenuated by suppressor of cytokine signalling (SOCS) proteins. Recent in vivo studies have highlighted the role of SOCS-3 in the negative regulation of signalling via gp130. To determine the role of SOCS-3 in ES cell biology, SOCS-3null ES cell lines were generated. When cultured in LIF levels that sustain self-renewal of wild-type cells, SOCS-3null ES cell lines exhibited less self-renewal and greater differentiation into primitive endoderm. The absence of SOCS-3 enhanced JAKSTAT and extracellular signalrelated kinase 1/2 (ERK-1/2)mitogen-activated protein kinase (MAPK) signal transduction via gp130, with higher levels of phosphorylated STAT-1, STAT-3, SH-2 domaincontaining cytoplasmic protein tyrosine phosphatase 2 (SHP-2), and ERK-1/2 in steady state and in response to LIF stimulation. Attenuation of ERK signalling by the addition of MAPK/ERK kinase (MEK) inhibitors to SOCS-3null ES cell cultures rescued the differentiation phenotype, but did not restore proliferation to wild-type levels. In summary, SOCS-3 plays a crucial role in the regulation of the LIF signalling pathway in murine ES cells. Its absence perturbs the balance between activation of the JAKSTAT and SHP-2ERK-1/2MAPK pathways, resulting in less self-renewal and a greater potential for differentiation into the primitive endoderm lineage.
This article has been cited by other articles:
![]() |
K. Boyle, P. Egan, S. Rakar, T. A. Willson, I. P. Wicks, D. Metcalf, D. J. Hilton, N. A. Nicola, W. S. Alexander, A. W. Roberts, et al. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo Blood, September 1, 2007; 110(5): 1466 - 1474. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
